A Phase 1 Study of MOMA-341 as Monotherapy or Combination Therapy in Participants with Advanced or Metastatic Solid Tumors
Clinical Trial Grant
Awarded By
MOMA Therapeutics, Inc.
Start Date
October 13, 2025
End Date
October 12, 2030
Awarded By
MOMA Therapeutics, Inc.
Start Date
October 13, 2025
End Date
October 12, 2030